GL1X · GenesisL1 explorer

Research workbench

Aleglitaar. a new. potent, and balanced dual PPARA/G agonist for the treatment of type II diabetes

Analyse Aleglitaar. a new. potent, and balanced dual PPARA/G agonist for the treatment… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3G9E
Type
protein
Length
268 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peroxisome proliferator-activated receptor gamma; Nuclear receptor coactivator 1
EC
2.3.1.48
UniProt
P37231, Q15788
Ligands
RO7
Pockets
2 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 68% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APeroxisome proliferator-activated receptor gammaprotein25868% helix, 5% strandP37231
BNuclear receptor coactivator 1 (EC 2.3.1.48)protein1070% helix, 0% strandQ15788

Ligands and binding sites

  • RO7 · (2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15070.800.8657RO7
2900.400.7714empty

Interfaces

1 interface between chains.

  • A–B · 535 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 3G9E · Aleglitaar. a new. potent, and balanced dual ppara/g agonist for the treatment of type II… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.